Stereotactic Radiosurgery for Tumors and Other Conditions

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

Recruiting Observational Study
Neoplasms Arteriovenous Malformation of Central Nervous System Trigeminal Neuralgia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
50,000 (estimated)
Sponsor
The Radiosurgery Society · Other
Who this trial is looking for

This trial is looking for patients with certain tumors or conditions that can be treated with stereotactic radiosurgery. If you participate, your treatment and outcomes will be tracked over time.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with benign or malignant tumors
  • I have a condition treatable by stereotactic radiosurgery
  • I am willing to sign an Informed Consent Document

You may not be able to join if

  • I am not willing to sign the Informed Consent Document
  • I decline participation

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included th…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy * Willingness to sign an Informed Consent Document or verbally agree to participation Exclusion Criteria: * There are no specific exclu…
Contacts

Jan Jenkins, RN

jjenkins@therss.org

CONTACT

Joanne Davis, PHD

jdavis@therss.org

CONTACT